- $32.91bn
- $38.66bn
- $15.26bn
- 80
- 77
- 84
- 94
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,220 | 4,828 | 12,206 | 19,169 | 15,258 |
Cost of Revenue | |||||
Gross Profit | 2,211 | 1,692 | 5,837 | 10,592 | 7,921 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6,075 | 7,682 | 8,992 | 11,200 | 10,289 |
Operating Profit | 145 | -2,854 | 3,214 | 7,969 | 4,969 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -109 | -3,090 | 2,898 | 7,775 | 4,623 |
Provision for Income Taxes | |||||
Net Income After Taxes | -79 | -2,543 | 2,833 | 6,037 | 3,782 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -355 | -2,680 | 2,813 | 6,015 | 3,747 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -357 | -2,684 | 2,783 | 5,958 | 3,747 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.149 | -2.05 | 4.27 | 9.1 | 5.8 |
Dividends per Share | |||||
Special Dividends per Share |